MUMBAI, Jan. 4 (Xinhua) — Indian companies have priced anti-COVID drug Molnupiravir at 0.5 U.S. dollars per capsule and will be available across retail pharmacies across the country from next week, Indian pharmaceutical companies Dr. Reddy’s Laboratories and Mankind Pharma said Tuesday.
The total treatment cost of 40 capsules over five days would cost 18.8 U.S. dollars, and the companies claimed that it would b